Ibsa Inst Drug Patent Portfolio
Ibsa Inst owns 1 orange book drug protected by 2 US patents Given below is the list of Ibsa Inst's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11344520 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | 20 Feb, 2035 | Active |
| US11351133 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | 20 Feb, 2035 | Active |
Latest Legal Activities on Ibsa Inst's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ibsa Inst.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Electronic Review
Critical
| 25 May, 2023 | US11351133 |
| Mail Certificate of Correction Memo | 24 May, 2023 | US11351133 |
| Post Issue Communication - Certificate of Correction | 22 May, 2023 | US11351133 |
| Certificate of Correction Memo | 22 May, 2023 | US11351133 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Jun, 2022 | US11351133 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Jun, 2022 | US11351133 |
|
Recordation of Patent Grant Mailed
Critical
| 31 May, 2022 | US11344520 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 31 May, 2022 | US11344520 |
|
Email Notification
Critical
| 19 May, 2022 | US11351133 |
|
Issue Notification Mailed
Critical
| 18 May, 2022 | US11351133 |
|
Application Is Considered Ready for Issue
Critical
| 13 May, 2022 | US11351133 |
| Dispatch to FDC | 13 May, 2022 | US11351133 |
|
Email Notification
Critical
| 12 May, 2022 | US11344520 |
|
Issue Notification Mailed
Critical
| 11 May, 2022 | US11344520 |
|
Email Notification
Critical
| 10 May, 2022 | US11351133 |
Ibsa Inst's Family Patents
Ibsa Inst Drug List
Given below is the complete list of Ibsa Inst's drugs and the patents protecting them.
1. Licart
Licart is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11344520 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug |
20 Feb, 2035
(9 years from now)
| Active |
| US11351133 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug |
20 Feb, 2035
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Licart's drug page